Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for
human uveitis and diabetic retinopathy.
(Besides this ambiguity in symptoms, it's just
human nature to first look for something curable, don't be cross with your veterinarian because of that) Inflammatory changes in an eye (
uveitis) are a textbook symptom of non-effusive FIP and will probably set off FIP alarm bells early on.